30 results about "Oral Lozenge" patented technology

The invention discloses a functional food and medicine for clearing the throat and a preparation method thereof. The product comprises the following main materials in parts by weight: 14.5-43.5 parts of honeysuckle flower extract, 40.3-120.9 parts of fructus monordicae extract, 22.5-67.5 parts of chrysanthemum extract, 23.5-70.5 parts of boat-fruited sterculia seed extract and 2.5-7.5 parts of menthol, and auxiliary materials comprise sorbitol and magnesium stearate. The product is prepared into an oral lozenge by weighing, mixing, granulating, drying and tabletting. The product is prepared from the honeysuckle flower extract, the fructus momordicae extract, the chrysanthemum extract, the boat-fruited sterculia seed extract and the menthol as the main raw materials. The compatibility of the whole formula is researched and developed according to the traditional Chinese medicine theory and the modern pharmacology, the honeysuckle flower is used for clearing away heat and toxic material,the fructus momordicae is used for entering the lung and spleen and clearing away the lung heat and moistening dryness and expelling phlegm and arresting coughing, the chrysanthemum is matched for dispelling wind heat, the boat-fruited sterculia seed is used for clearing internal heat and relieving the throat, and the fresh sweet menthol is used for avoiding dirt and clearing away toxic material and clearing away the damp-heat from the throat, thereby forming a sweet and cool nourishing preparation for generating the effects of relieving and moistening the throat by synergism.

The invention provides a hemsley rockvine root lozenge for diminishing inflammation and resisting viruses and a preparation method thereof. The preparation method provided by the invention can be used for preparing a lozenge which keeps the original nutrient substance components and has the functions of diminishing inflammation and resisting viruses. The advanced technology is used for deeply processing the hemsley rockvine root, i.e. the hemsley rockvine root is treated by the processes of cleaning, crushing, microwave extraction, enzymatic saccharification, secondary filtration, spray drying, granulating, tabletting and the like, thus the hemsley rockvine root fully exerts the medical properties in the preparation process, and the effective components of the hemsley rockvine root are furthest protected. The Chinese herbal medicine hemsley rockvine root is prepared into an oral lozenge which can be carried simply, saved easily and taken conveniently and has the functions of diminishing inflammation and resisting viruses. The high-concentration medical lozenge can sterilize the oral throat and can enter a human body, so that the hemsley rockvine root can exert the functions of resisting bacteria, diminishing inflammation, resisting viruses and improving immunity. By orally taking the hemsley rockvine root lozenge for diminishing inflammation and resisting viruses, the bacteria in the oral cavity can be effectively sterilized, and upper respiratory tract communicable diseases such as influenza and the like can be prevented.

Extraction of cynanchum bunqei polysaccharide and preparation of its oral tablets pharmaceutics are achieved by: pulverizeing cynanchum bunqei (granular <4mm), Reflux extracting two to three times in 3-10 times alcohol . The extracted liquid is concentrated to recover for other uses. The extracted solid residues was extracted three times in certain ratio 1: 8-20 of materials and water at 80deg.C-100deg.C for 1-3 h, then incorporating the aquatic extracted liquid. The aquatic extracted liquid was concentrated, depositing with alcohol and drying to obtain cynanchum bunqei crude polysaccharide. The aquatic extracted liquid was destarch by enzyming, deproteinizing by chloroform- normal butanol method, depositing with alcohol and drying to get cynanchum bunqei total polysaccharide. The animal testing in vivo and testing in vitro prove that, the polysaccharide and total polysaccharide are capable of preparing pharmaceuticals as componets of immunoregulation fuctions and health-care food such as buccal tablets and oral liquid.

The invention relates to an oral pharmaceutical composition for lowering blood lipid, and particularly relates to a pharmaceutical composition with any one substance of ezetimibe and nicotinic acid lipid-lowering drugs or Beite lipid-lowering drugs as an active ingredient as well as a preparation and application thereof. The pharmaceutical composition is an oral preparation prepared from ezetimibe and nicotinic acid lipid-lowering drugs or Beite lipid-lowering drugs used as the active ingredient and corresponding pharmaceutical auxiliary materials according to the technique and method provided by the invention; and the pharmaceutical composition can be prepared into granules, common tablets, chewing tablets, dispersing tablets, oral disintegrating tablets, oral lozenge, capsules, soft capsules, dropping pills, sustained-release tablets, sustained-release capsules and the like. The pharmaceutical composition has rapid and durable action, is convenient to take, and can be used for treating various types of hyperlipemia.

The present invention provides for compositions including nicotine salts, solutions thereof, methods of manufacture and methods of use. Certain embodiments provide for the delivery of the compositionsincluding by: transdermal, oral, nasal and inhalation modes. Certain embodiments provide nicotine salts and solutions thereof, suitable for or packaged in or with devices including: oral lozenges, chewing gum, transdermal patches, intranasal sprays and intranasal inhalers, e-liquids and e-cigarette or vaping devices.

The present invention relates to plasmin producing strain and method of producing plasmin, and belongs to the field of food biotechnology. The present invention screens out one plasmin strain with thrombolysis capacity from fermented food shrimp paste, and the new strain is identified as one new variety of bacillus, and named as Bacillus sp.nov.SK006 and has the preservation number of CCTCC No. M205071. The present invention also provides method of producing plasmin with the said strain, and the method has less breeding work, low cost, high safety and reliability and may be used in large scale liquid fermentation production. The fermented product is non-toxic, and may be used in preparing capsule, granule, oral liquid or oral lozenge or as additive for health food or common food.

The invention relates to an acetaminophen and tramadol co-soluble compound analgesic oral liquid. The oral liquid is prepared from by weight, 1.447-6.702% of acetaminophen, 0.167%-0.773% of tramadol and 90.828%-98.02% of a solution system comprising glycerol, pure water and polyethylene glycol which independently accounts for 17-65% by weight, wherein the total weight percentage of the liquid is counted as 100%. The oral liquid is used for solving the problem that oral lozenge analgesics are difficult to use because it is difficult to swallow the analgesics.

The present invention relates to health food, and especially a kind of health food containing emblic extract. The health food contains effective components comprising emblic extract in 20-99.98w and IgY in 0.02-80 wt%. The health food may be prepared into oral lozenge or beverage after adding proper amount of supplementary material. The health food of the present invention can raise the function of K+-Na+ pump in body's cell membrane to make energy source and bioactive matters enter to body fast, so as to promote the energy metabolism and inorganic matter metabolism, regulate water-electrolyte metabolism, resist anoxia and eliminating fatigue fast.

The present invention relates to medicine, and is medicine for treating radioactive mucous membrane damage, recurrent aphtha and paradentitis. The medicine contains SOD, vitamin B12 and vitamin B2, and may be aerosol or oral lozenge. The aerosol product has the components of SOD 20000-100000 IU, vitamin B12 0.001-0.005 g and vitamin B2 0.005-0.015 g. The oral lozenge product has the components of SOD 1000-4000 IU, vitamin B12 0.000009-0.00009 g and vitamin B2 0.0002-0.0008 g. The medicine has wide material source, low cost, and other advantages.

The invention relates to anti-aging lozenges. The anti-aging lozenges are characterized by comprising components in percentage by mass as follows: 10%-25% of grape seed extract, 15%-35% of tea extract, 6%-12.5% of ganoderma lucidum, 5%-10% of largehead atractylodes rhizomes, 13%-20% of fructus lycii, 7%-16.5% of south dodder seeds and 1%-5% of syrup. According to the anti-aging lozenges, the grape seed extract and the tea extract are taken as active additives and added to the lozenges and have higher oxidation resistance and free radical scavenging capability; compared with other anti-aging agents, the composition can scavenge harmful free radicals and has an excellent ageing resistance function; the anti-aging lozenges are added with the ganoderma lucidum, the largehead atractylodes rhizomes, the fructus lycii and the south dodder seeds, contain multiple traditional Chinese medicine active ingredients and can promote metabolism of cells of a human body; the oral lozenges are prepared after the syrup is added, and the lozenges taste good during taking and are easily absorbed by the human body.

The invention relates to an oral nursing composition and application thereof. The oral nursing composition contains cannabidiol and sodium gualenate. The invention creatively finds that the cannabidiol and the sodium gualenate have a synergistic interaction effect during oral nursing; compared with independent use of the cannabidiol or the sodium gualenate, the composition consisting of the cannabidiol and the sodium gualenate has better effects of resisting inflammation, repairing oral mucosae and easing pain and has remarkable effects on treatment of oral problems such as periodontitis, gingivitis and dental ulcer, and an oral product prepared from the composition is flexible and inirritative in taste and high in experience level. The composition can be applied to oral nursing products such as toothpaste, tooth powder, mouth wash, oral sprays, oral stickers, chewing gum or oral lozenges.

The present invention provides for compositions including nicotine salts, solutions thereof, methods of manufacture and methods of use. Certain embodiments provide for the delivery of said compositions including by: transdermal, oral, nasal and inhalation modes. Certain embodiments provide nicotine salts and solutions thereof, suitable for or packaged in or with devices including: oral lozenges, chewing gum, transdermal patches, intranasal sprays and intranasal inhalers, e-liquids and e-cigarette or vaping devices.

The invention discloses a composite traditional Chinese medicine lozenge which has effects of clearing away heat and toxic materials and relieving swelling and stopping pain, as well as a preparation method and application thereof, and belongs to the field of traditional Chinese medicine preparations. The composite traditional Chinese medicine lozenge consists of the following components in percentage by weight: 4-10% of a Chinese violet extract, 1-5% of a dandelion extract and 85-95% of medicinal auxiliary materials. The invention further discloses a method for preparing the composite traditional Chinese medicine lozenge. The method comprises main processes of preparing the Chinese violet extract, preparing the dandelion extract and preparing the composite traditional Chinese medicine lozenge. In addition, the invention further discloses application of the composite traditional Chinese medicine lozenge in preparing a medicine for treating pharyngitis. Compared with a preparation for treating pharyngitis in the market, the composite traditional Chinese medicine lozenge disclosed by the invention is concise and special in medicinal effect, can treat both symptoms and root causes and is good in specificity as the medicine is retained at focuses of throats for a long time and the medicinal effects can be brought into play rapidly and continuously; meanwhile, by adopting the oral lozenge, the first pass effect of livers can be avoided, and the bioavailability can be high.

The invention relates to a preparation method for lozenges for preventing and treating oral ulcer, in particular to application of a pearl powder or pearl layer powder and crystalline fructose composition in preparing of the oral ulcer lozenges. The oral lozenges capable of preventing and treating the oral ulcer consists of 1-2 parts of pearl layer powder and 2-5 parts of crystalline fructose andhave the good preventing and treating effects on the multiple and recurrent oral ulcer. The invention further discloses a formula and production technology for preparing the lozenges through the method that several vitamins and traditional Chinese medicine constituents, such as traditional Chinese medicine radix glycyrrhizae, fructus mume, exocarpium citri rubrum, dandelions and honeysuckle, withthe anti-inflammatory and antimicrobial effects are added into the composition. The lozenges for preventing and treating the oral ulcer through the preparation method have the effects of being antibacterial, anti-inflammatory, analgesic and capable of promoting ulcer healing, can be clinically used for prevention and treatment of the oral ulcer caused by various reasons, and can also be used for prevention and treatment of oral inflammation such as gingival tumefaction, pharyngitis, laryngitis and amygdalitis.

The present invention relates to health food, and especially a kind of health food containing emblic extract. The health food contains effective components comprising emblic extract in 20-99.98w and IgY in 0.02-80 wt%. The health food may be prepared into oral lozenge or beverage after adding proper amount of supplementary material. The health food of the present invention can raise the function of K+-Na+ pump in body's cell membrane to make energy source and bioactive matters enter to body fast, so as to promote the energy metabolism and inorganic matter metabolism, regulate water-electrolyte metabolism, resist anoxia and eliminating fatigue fast.

The invention discloses a rose-donkey-hide gelatin-Chinese yam oral buccal tablet and a preparation method thereof, and belongs to the field of rose processed foods. The rose-donkey-hide gelatin-Chinese yam oral buccal tablet is prepared from the following raw materials in parts by weight: 30-50 parts of a rose dried powder, 10-20 parts of a donkey-hide gelatin powder, 10-20 parts of a Chinese yam powder, 10-20 parts of a red jujube powder, 10-20 parts of a hawthorn powder, and 5-10 parts of honey. The technological process of the prepared rose-donkey-hide gelatin-Chinese yam oral buccal tablet adopts a physical way, various nutritional ingredients are not destroyed, the nutritional value is improved, moreover, the nutritional value is more comprehensive, and the role of food curative effect can be fully played; oxidation of anthocyanin in flowers of rosa rugosa cv.plena is also prevented, and the content of the anthocyanin in the rose-donkey-hide gelatin-Chinese yam oral buccal tablet is determined to be 105.56 mg / 100 g by Shandong academy of agricultural sciences.

The invention relates to a bactericide for being taken after swimming. The bactericide is prepared by the steps of grinding five medicaments into powder, and compressing the powder into an oral lozenge, wherein the five medicaments are as follows: 20-40 parts of radix scutellariae, 14-25 parts of fructus forsythia, 30-60 parts of ramulus cinnamomi, 15-30 parts of akebia stem and 20-35 parts of herba violae. The bactericide has relatively strong effects on the killing of main pathogenic bacteria in a swimming pool and is capable of effectively killing bacteria entering oral cavities and esophaguses.

The invention discloses an oral lozenge for improving immunity. The oral lozenge for improving immunity comprises, by weight parts, 10-30 parts of dry sweet wormwood stem cell powder, 0.1-0.4 part of freshener, 0.2-0.6 part of sweetening agent, 1-5 parts of maltodextrin, 0.8-2 parts of citric acid, 0.8-2 parts of magnesium stearate and 2-6 parts of water. Compared with the prior art, the oral lozenge has the advantages that sweet wormwood stem cells are cultivated, cell culture thereof is extracted and made into dry powder, the dry powder is pressed into the lozenge, and the lozenge is good in palatability and convenient to carry and eat and can enhance immunity now.

The invention discloses a compound tetrastigma hemsleyanum pharyngitis lozenge and a preparation method thereof. The lozenge is prepared from a tetrastigma hemsleyanum extract powder prepared from the tetrastigma hemsleyanum with botrychium officinale and roots of imperata cylindrica, mannitol powder and aspartame as raw materials, with ethanol as a wetting agent and with addition of menthol and magnesium stearate. The oral lozenge is prepared through following steps: preparation of the extract powder, mixing of a filling agent, preparation of a soft material, granulation, a drying process, a granule reshaping process, a lozenge pressing process and a sterilizing and packaging process. The lozenge has a broad-spectrum antibacterial effect and a strong anti-respiratory syncytial virus and anti-influenza virus effect. In addition, the lozenge also has a certain inhibiting effect on staphylococcus aureus, pneumococcus, hemolytic streptococcus, shigella dysenteriae and the like. The lozenge can act on a disease location for a long period when being applied locally and a curative effect can be achieved maximumly. In addition, defects in orally-taking of traditional Chinese medicines and western medicines are overcome. The lozenge is sweet in taste, is refreshing in flavor, is good in mouthfeel and disintegration, is convenient to use, is easy to take and is suitable for people in various age.

The invention provides an oral slow release influenza vaccine and a preparation method thereof. The invention is a divisional application of Chinese patent application 200910103512X, comprises preparation methods for a whole virus inactivated vaccine, a cracking vaccine and a subunit vaccine and relates to a novel influenza oral lozenge or oral slow release vaccine preparation which is suitable to be orally taken and a preparation process thereof. The preparation method comprises preparation of a virus seed bank, production and preparation of vaccine stock solution, addition and freeze-dryingof a protectant and an excipient, composition of the oral lozenge or the oral slow release preparation, a forming process and the like. Through the oral influenza vaccine, pain and discomfort caused by injection can be avoided, a natural infection approach is simulated, the contact of most of mucous membrane surface region and the vaccine can be guaranteed, and immunological reaction of the mucous membrane and immunological reaction of a system are caused; the vaccine is not required to be produced under an extremely strict condition and is low in cost, and the cost required by increase in amount of required antigen can be relatively reduced; and the oral vaccine is convenient to use, is not required to be inoculated by a professional and is convenient to store and transport.

The present invention is a preparation method of a composition for relieving vomiting of pregnant women. The preparation method of the composition comprises the following steps: (1) decoction; (2) juice extraction; (3) the prepared product can be taken as oral buccal tablets or granules or oral liquid. The composition of the present invention is well matched to prepare granules and oral liquid for the reference of pregnant women with mild vomiting, while the tablet is mainly for pregnant women with severe vomiting, and the composition can not only relieve the vomiting of pregnancy reaction, etc. Symptoms can also add necessary nutrients to pregnant women, and the good combination of various substances makes each substance play the best effect. The invention can effectively relieve the vomiting phenomenon of pregnant women, has good taste, has no toxic and side effects after repeated verification, and is suitable for pregnant women to eat.

The invention provides a hemsley rockvine root lozenge for diminishing inflammation and resisting viruses and a preparation method thereof. The preparation method provided by the invention can be used for preparing a lozenge which keeps the original nutrient substance components and has the functions of diminishing inflammation and resisting viruses. The advanced technology is used for deeply processing the hemsley rockvine root, i.e. the hemsley rockvine root is treated by the processes of cleaning, crushing, microwave extraction, enzymatic saccharification, secondary filtration, spray drying, granulating, tabletting and the like, thus the hemsley rockvine root fully exerts the medical properties in the preparation process, and the effective components of the hemsley rockvine root are furthest protected. The Chinese herbal medicine hemsley rockvine root is prepared into an oral lozenge which can be carried simply, saved easily and taken conveniently and has the functions of diminishing inflammation and resisting viruses. The high-concentration medical lozenge can sterilize the oral throat and can enter a human body, so that the hemsley rockvine root can exert the functions of resisting bacteria, diminishing inflammation, resisting viruses and improving immunity. By orally taking the hemsley rockvine root lozenge for diminishing inflammation and resisting viruses, the bacteria in the oral cavity can be effectively sterilized, and upper respiratory tract communicable diseases such as influenza and the like can be prevented.

Extraction of cynanchum bunqei polysaccharide and preparation of its oral tablets pharmaceutics are achieved by: pulverizeing cynanchum bunqei (granular <4mm), Reflux extracting two to three times in 3-10 times alcohol . The extracted liquid is concentrated to recover for other uses. The extracted solid residues was extracted three times in certain ratio 1: 8-20 of materials and water at 80deg.C-100deg.C for 1-3 h, then incorporating the aquatic extracted liquid. The aquatic extracted liquid was concentrated, depositing with alcohol and drying to obtain cynanchum bunqei crude polysaccharide. The aquatic extracted liquid was destarch by enzyming, deproteinizing by chloroform- normal butanol method, depositing with alcohol and drying to get cynanchum bunqei total polysaccharide. The animal testing in vivo and testing in vitro prove that, the polysaccharide and total polysaccharide are capable of preparing pharmaceuticals as componets of immunoregulation fuctions and health-care food such as buccal tablets and oral liquid.

The present invention relates to medicine, and is medicine for treating radioactive mucous membrane damage, recurrent aphtha and paradentitis. The medicine contains SOD, vitamin B12 and vitamin B2, and may be aerosol or oral lozenge. The aerosol product has the components of SOD 20000-100000 IU, vitamin B12 0.001-0.005 g and vitamin B2 0.005-0.015 g. The oral lozenge product has the components of SOD 1000-4000 IU, vitamin B12 0.000009-0.00009 g and vitamin B2 0.0002-0.0008 g. The medicine has wide material source, low cost, and other advantages.

The invention relates to the field of oral lozenges, in particular to a yellow peach flavored roxburgh rose lozenge and a preparation method thereof. The yellow peach flavored roxburgh rose lozenge is prepared from the following components in parts by mass: 40 to 60 parts of roxburgh rose fruit dry powder, 40 to 60 parts of roxburgh rose rhizome dry powder, 1 to 5 parts of yellow peach flavor agent, 0.1 to 0.4 part of melatonin, 0.01 to 0.02 part of sodium pyrosulfite and 0.1 to 1 part of tocopherol. The yellow peach flavored roxburgh rose lozenge disclosed by the invention takes the roxburgh rose fruit dry powder and the roxburgh rose rhizome dry powder as main raw materials, the roxburgh rose fruit dry powder is rich in ascorbic acid, the roxburgh rose rhizome dry powder is rich in lactic acid and malic acid, additional flavor can be provided, and meanwhile, the melatonin, the sodium pyrosulfite and the tocopherol are also added as protective agents, so that the attenuation of ascorbic acid and SOD can be effectively prevented.

According to the SARS-CoV-2 yolk neutralizing antibody IgY spray for preventing and treating the new coronal pneumonia, the yolk neutralizing antibody IgY is a polyclonal antibody, comprises a new coronal virus S1 protein receptor binding domain antibody or a new coronal virus S2 protein antibody, and can block the binding of a new coronal virus and a cell receptor ACE2, neutralize the new coronal virus SARS-CoV-2, block the infection of the new coronal virus and inhibit and kill the virus; new crown pneumonia is prevented and treated; the S protein, the S1 protein, the RBD protein or the S2 protein of the new coronavirus is used as an antigen to immunize an egg laying hen, and the egg yolk antibody IgY is extracted from egg yolk. The invention provides an anti-new coronavirus yolk neutralizing antibody IgY preparation which can be a spray, an eye drop, an oral capsule or an oral lozenge. The action mode is safe, large-scale production is easy, immunological rejection is not generated, and a safe, simple, sanitary, effective and economical personalized epidemic prevention mode is created to deal with epidemic situations.

The invention discloses an oral lozenge with the effect of relieving toothache symptoms. The oral lozenge is prepared from, by mass, 15-25 parts of fructus forsythiae, 5-15 parts of mint, 20-45 partsof draconis sanguis, 20-35 parts of caesalpinia sappan and 20-45 parts of raw kusnezoff monkshood roots, and the five components are ground into powder to be compressed to prepare into the oral lozenge. The oral lozenge is convenient to use, inflammation diminishing and sterilization can be effectively carried out, and bacteria in the oral cavity are reduced; meanwhile, sensory nerves are anesthetized, the sensitivity degree of the sensory nerves in the oral cavity can be reduced, and the uncomfortable excitement feeling is reduced.

The present invention relates to plasmin producing strain and method of producing plasmin, and belongs to the field of food biotechnology. The present invention screens out one plasmin strain with thrombolysis capacity from fermented food shrimp paste, and the new strain is identified as one new variety of bacillus, and named as Bacillus sp.nov.SK006 and has the preservation number of CCTCC No. M205071. The present invention also provides method of producing plasmin with the said strain, and the method has less breeding work, low cost, high safety and reliability and may be used in large scale liquid fermentation production. The fermented product is non-toxic, and may be used in preparing capsule, granule, oral liquid or oral lozenge or as additive for health food or common food.

The invention discloses a functional food and medicine for clearing the throat and a preparation method thereof. The product comprises the following main materials in parts by weight: 14.5-43.5 parts of honeysuckle flower extract, 40.3-120.9 parts of fructus monordicae extract, 22.5-67.5 parts of chrysanthemum extract, 23.5-70.5 parts of boat-fruited sterculia seed extract and 2.5-7.5 parts of menthol, and auxiliary materials comprise sorbitol and magnesium stearate. The product is prepared into an oral lozenge by weighing, mixing, granulating, drying and tabletting. The product is prepared from the honeysuckle flower extract, the fructus momordicae extract, the chrysanthemum extract, the boat-fruited sterculia seed extract and the menthol as the main raw materials. The compatibility of the whole formula is researched and developed according to the traditional Chinese medicine theory and the modern pharmacology, the honeysuckle flower is used for clearing away heat and toxic material,the fructus momordicae is used for entering the lung and spleen and clearing away the lung heat and moistening dryness and expelling phlegm and arresting coughing, the chrysanthemum is matched for dispelling wind heat, the boat-fruited sterculia seed is used for clearing internal heat and relieving the throat, and the fresh sweet menthol is used for avoiding dirt and clearing away toxic material and clearing away the damp-heat from the throat, thereby forming a sweet and cool nourishing preparation for generating the effects of relieving and moistening the throat by synergism.

The invention discloses an oral lozenge capable of relieving bronchiectasis. The oral lozenge is prepared by the following steps: grinding herba asari, olibanum, crinis trachycarpi, rhizoma bletillae and borax into powder and mixing together with monoglyceride. The oral lozenge has the effects of contracting bronchus and diminishing inflammation and inhibiting bacteria, can promote the dilated bronchus to be healed, and is convenient in usage and obvious in effects.